IL15 and neoplasm: Bi-specific and tri-specific killer engagers (BiKE and TriKE molecules, respectively) also engage CD16 and tumor targets, with TriKEs the first to also incorporate an IL-15 moiety, delivering additional increased NK cell proliferation and survival signals [185].